Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BIO | US
6.42
2.28%
Healthcare
Diagnostics & Research
30/06/2024
24/04/2026
287.84
281.61
288.49
280.35
Bio-Rad Laboratories Inc. manufactures and distributes life science research and clinical diagnostic products in the United States Europe Asia Canada and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops manufactures and markets reagents apparatus and laboratory instruments that are used in research techniques biopharmaceutical production processes and food testing regimes. It focuses on selected segments of the life sciences market in proteomics genomics biopharmaceutical production cellular biology and food safety. This segment serves universities and medical schools industrial research organizations government agencies pharmaceutical manufacturers biotechnology researchers food producers and food testing laboratories. The Clinical Diagnostics segment designs manufactures sells and supports test systems informatics systems test kits and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents instruments and software which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories hospital laboratories state newborn screening facilities physicians' office laboratories and transfusion laboratories. In addition the company offers products and systems to separate complex chemical and biological materials as well as to identify analyze and purify components. The company offers its products through its direct sales force as well as through distributors agents brokers and resellers. Bio-Rad Laboratories Inc. was founded in 1952 and is headquartered in Hercules California.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Price Below SMA10D
High Short-term Volatility
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
43.4%1 month
36.1%3 months
38.4%6 months
34.8%-
30.96
1.42
0.21
0.14
-13.07
3.66
1.19
514.17M
7.97B
7.97B
-
15.74
479.70
-6.30
-17.41
1.73
4.95
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
37.95
Range1M
48.62
Range3M
62.41
Rel. volume
0.61
Price X volume
42.42M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Charles River Laboratories International Inc | CRL | Diagnostics & Research | 169.8 | 8.77B | 1.23% | 23.63 | 76.32% |
| QIAGEN N.V | QGEN | Diagnostics & Research | 38.41 | 8.54B | 1.16% | 122.86 | 41.16% |
| ICON Public Limited Company | ICLR | Diagnostics & Research | 102.17 | 8.46B | -3.92% | 34.54 | 37.38% |
| Lantheus Holdings Inc | LNTH | Diagnostics & Research | 84.33 | 5.86B | 1.82% | 19.19 | 60.42% |
| Bruker Corporation | BRKR | Diagnostics & Research | 36.55 | 5.53B | 0.91% | 26.13 | 126.86% |
| Celcuity Inc | CELC | Diagnostics & Research | 121.03 | 4.48B | 6.58% | n/a | 54.62% |
| Sotera Health Company | SHC | Diagnostics & Research | 15.58 | 4.41B | 1.63% | 114.29 | 555.18% |
| RadNet Inc | RDNT | Diagnostics & Research | 57.63 | 4.26B | 2.11% | 378.67 | 195.04% |
| Senseonics Holdings Inc | SENS | Diagnostics & Research | 7.05 | 3.78B | 0.71% | n/a | 154.97% |
| Twist Bioscience Corporation | TWST | Diagnostics & Research | 60.94 | 3.57B | 3.55% | n/a | 17.75% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Dolby Laboratories Inc | DLB | Media - Diversified | 64.08 | 6.11B | 1.78% | 34.32 | 0.00% |
| FBIN | FBIN | Building Products & Equipment | 41.54 | 5.16B | 0.34% | 25.57 | 130.24% |
| Thor Industries Inc | THO | Recreational Vehicles | 79 | 4.18B | 0.24% | 23.44 | 27.88% |
| Cinemark Holdings Inc | CNK | Media - Diversified | 28.48 | 3.49B | -0.42% | 27.93 | 934.91% |
| VeriFone Systems Inc | PAY | Building Products & Equipment | 27.25 | 3.39B | 0.96% | 102.46 | 2.10% |
| Polaris Industries Inc | PII | Recreational Vehicles | 60.04 | 3.35B | 1.06% | 14.48 | 170.51% |
| LCI Industries | LCII | Recreational Vehicles | 120.01 | 3.06B | -0.45% | 25.82 | 77.66% |
| Harley-Davidson Inc | HOG | Recreational Vehicles | 23.11 | 3.04B | -1.15% | 7.33 | 218.58% |
| Pitney Bowes Inc | PBI | Building Products & Equipment | 15.58 | 2.80B | 1.37% | n/a | -571.93% |
| IMAX Corporation | IMAX | Media - Diversified | 36.45 | 1.92B | -0.44% | 54.26 | 110.44% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -13.07 | 12.67 | Cheaper |
| Ent. to Revenue | 3.66 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 1.42 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 38.39 | 59.59 | Lower Risk |
| Debt to Equity | 0.21 | -14.36 | Expensive |
| Debt to Assets | 0.14 | 0.34 | Cheaper |
| Market Cap | 7.97B | 13.71B | Emerging |